The Microarray and Beyond: Genetic Testing for Neurodevelopmental Disorders

  • Join us as we review genetic testing for neurodevelopmental disorders and Ambry’s newest suite of tests for these patients. This webinar will review genetic testing that will provide answers for a variety of neurodevelopmental disorders.

Clinical Genomics Product Manager, Ambry Genetics

Layla is the Clinical Genomics Product Manager at Ambry genetics where she manages the clinical exome sequencing and microarray tests.  In her previous role, Layla was a reporting genetic counselor where she focused on reporting results for exome sequencing for 3 years.  Layla has a particular interest in secondary findings and has been involved with several projects, publications and policy involving secondary findings at Ambry Genetics as well as for her thesis project in graduate school.  Layla received her M.S. in Genetic Counseling from Stanford University School of Medicine in 2012 and has been board certified since 2014. 

Genetic Counselor

Devon is a genetic counselor for the Launch Team at Ambry, where she helps getting new clinical tests added to the diagnostic testing menu. Devon previously worked as a laboratory genetic counselor at Nationwide Children’s Hospital focusing on reporting, test development, test utilization management, and teaching. She has a particular interests in genetic technologies, variant and copy number assessment, pediatric genetics, and teaching. She currently is a contributing faculty member for the Northwestern University Graduate Program in Genetic Counseling as well as a member of the ClinGen Education, Engagement and Counseling Workgroup. Devon received her M.S. in Genetic Counseling from Case Western Reserve University in 2004, and has been Board-certified since 2005.

  • Tue, March 29, 2016
  • 8:40am PDT
  • Duration: 58 minutes
  • C.E.U. --
  • P.A.C.E. --

Webinar Newsletter

Subscribe to our webinar newsletter for updates, sent out every month.

Subscribe

Search Results

Start your search...